NCT05640778 2024-01-31
Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
Clinical Trials
12 trialsNCT02914158 2023-01-17
ASPAIT
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown
NCT04012918 2019-07-09
CONCEPT
Ain Shams University
Phase 2 Unknown
NCT03910712 2019-04-10
Pyrotinib
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02769104 2018-01-09
ACCN
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT02910050 2017-12-22
BETTER
Sun Yat-sen University
Phase 2 Unknown
NCT03111615 2017-12-05
HOTBreast
Centro Hospitalar Lisboa Ocidental
Phase 4 Unknown
NCT02467686 2017-03-20
Cimicifuga
Irmandade da Santa Casa de Misericordia de Sao Paulo
Phase 4 Unknown
NCT02394496 2016-06-15
OVER
Consorzio Oncotech
Phase 3 Unknown
NCT01924078 2013-08-16
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
Fudan University
Phase 2 Unknown
NCT00629278 2013-08-07
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01793038 2013-03-06
Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
Mansoura Integrated Fertility Center
Phase NA Unknown